This topic contains a solution. Click here to go to the answer

Author Question: The nurse is presenting community education regarding self-treatment of heartburn with antacids. As ... (Read 25 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
The nurse is presenting community education regarding self-treatment of heartburn with antacids. As part of this discussion, the nurse advises people with which conditions to avoid antacids?
 
  1. People with low calcium levels.
  2. Those with diminished renal function.
  3. Women who are perimenopausal.
  4. People who are on sodium-restricted diets.
  5. People with coronary artery disease.

Question 2

What are the weaknesses of the Dietary Supplement Health and Education Act (DSHEA)?(Select all that apply.)
 
  1. The manufacturer does not need to prove the safety of the supplement.
  2. The accuracy of the label is not regulated.
  3. The FDA can remove products from the market if they pose a significant risk.
  4. Dietary supplements do not need to be tested prior to marketing.
  5. Dietary supplements are safe for everyone to use.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lou

  • Sr. Member
  • ****
  • Posts: 286
Answer to Question 1

2,4
Rationale 1: Calcium antacids are often used as calcium supplements.
Rationale 2: Diminished renal function is a reason to avoid self-directed antacid use.
Rationale 3: There is no reason for perimenopausal women to avoid antacids.
Rationale 4: Many over-the-counter antacids contain significant amounts of sodium.
Rationale 5: There is no reason for those with coronary artery disease to avoid antacids.

Global Rationale: Diminished renal function is a reason to avoid self-directed antacid use. Many over-the-counter antacids contain significant amounts of sodium. Calcium antacids are often used as calcium supplements. There is no reason for perimenopausal women to avoid antacids. There is no reason for those with coronary artery disease to avoid antacids.

Answer to Question 2

1, 2, 4

Rationale 1:A weakness of the DSHEA is that the manufacturer does not need to prove the safety of the supplement.
Rationale 2:Aweakness of the DSHEA is that the accuracy of the label is not regulated.
Rationale 3: The FDA can remove products from the market if they pose a significant risk, which is a strength of the DSHEA.
Rationale 4:A weakness of the DSHEA is that dietary supplements do not need to be tested prior to marketing.
Rationale 5:The safety of dietary supplements differs for each client. This is neither a strength nor a weakness.

Global Rationale: The FDA can remove products from the market if they pose a significant risk, which is a strength of the DSHEA. Weaknesses of the DSHEA are that the manufacturer does not need to prove the safety of the supplement, the accuracy of the label is not regulated, and dietary supplements do not need to be tested prior to marketing. The safety of dietary supplements differs for each client. This is neither a strength nor a weakness.




strangeaffliction

  • Member
  • Posts: 660
Reply 2 on: Jul 23, 2018
Wow, this really help


Kedrick2014

  • Member
  • Posts: 359
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library